Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHGH for Weaning Prolonged Ventilation After Abdominal Cancer Surgery
NCT03717168Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2018
- Primary completion
- Aug 2018
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of somatropin in prolonged mechanical ventilation (PMV) (2 arms), sponsored by National Cancer Institute. Primary endpoint: The effect of rHGH on the mechanical ventilation time up to 6 weeks. Started Mar 2018; status: completed.
02
Drugs
somatropin
03
Conditions
prolonged mechanical ventilation (PMV)
Beyond the preview
Go deeper on NCT03717168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717168.